Robert J. DelAversano is VP & Finance at ONCOSEC MEDICAL Inc (ONCS). They have made 8 open-market trades across 1 company since 2021, most recently 2023-02-09.
CIK 0001728262
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 8 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ONCS | 1,008 | $279 |
Shares reported on the most recent Form 4, priced at the 2023-02-09 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ONCS | SELL | 2023-02-09 | 2023-02-09 | $1.37 | $55 | -17.7% | +105.0% | -41.6% |
| ONCS | SELL | 2022-11-04 | 2022-11-04 | $0.37 | $105 | -51.1% | -68.0% | -79.8% |
| ONCS | SELL | 2022-08-05 | 2022-08-05 | $0.71 | $202 | -4.3% | -8.6% | -49.2% |
| ONCS | SELL | 2022-05-06 | 2022-05-06 | $0.83 | $227 | -8.8% | +5.9% | -8.9% |
| ONCS | SELL | 2022-02-09 | 2022-02-11 | $0.88 | $360 | -7.6% | +0.8% | -26.9% |
| ONCS | SELL | 2021-11-01 | 2021-11-03 | $1.75 | $600 | -8.1% | -34.1% | -48.7% |
| ONCS | SELL | 2021-08-02 | 2021-08-03 | $2.18 | $898 | +11.6% | +7.9% | -18.6% |
| ONCS | SELL | 2021-05-03 | 2021-05-04 | $4.86 | $2K | -26.8% | -18.4% | -53.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.